Haier Biomedical News
Revolutionizing Cold Chain Technology with HB
The landscape of the global medical and pharmaceutical industry is undergoing rapid transformation fuelled by cutting-edge medicines, vaccines, biologics, and stem cell products. This evolution extends to the equipment realm encompassing medical refrigerated trucks, cold storage facilities, and medical incubators. The robust growth of the medical cold chain market signifies a shift towards elevated standards, seamless integration, automation, and modernization. Standing at the forefront of this dynamic sector is Haier Biomedical–a distinguished global leader in delivering comprehensive cold chain solutions. Armed with unparalleled expertise, extensive industry experience, and an unwavering commitment to innovation, Haier Biomedical sets the benchmark for ensuring the safety and efficiency of the global cold chain network.
HB Supports Oxford Research Centre
Haier Biomedical recently delivered a large cryogenic storage system to support multiple myeloma research at the Botnar Institute for Musculoskeletal Sciences in Oxford. This institute is Europe's largest center for studying musculoskeletal conditions, boasting state-of-the-art facilities and a team of 350 staff and students. The cryogenic storage facility, a part of this infrastructure, attracted the Oxford Centre for Translational Myeloma Research, aiming to centralize its tissue samples.
HB's Liquid Nitrogen Containers: The Guardian of IVF
Every second Sunday of May is a day to honour great mothers. In today's world, in vitro fertilization (IVF) has become a crucial method for many families to fulfil their dreams of parenthood. The success of IVF technology hinges on the careful management and protection of embryos and germ cells. Haier Biomedical’s liquid nitrogen containers play a vital role in maintaining stable cell activity within a low-temperature environment, serving as an ideal storage solution for umbilical cord blood, tissue cells, and various biological samples. This innovative technology provides essential support for IVF procedures, ensuring a smoother journey towards motherhood.
HB Attains Remarkable Milestones in the Hong Kong Market
In early May, Haier Biomedical once again announces ground-breaking developments in the Hong Kong market. Following numerous university acquisitions of centrifuge equipment in 2023, both Hong Kong Science Park and the University of Hong Kong have completed their equipment installations, leading to a significant increase in the penetration of medical groups within universities.
Empowering Global Health: Haier Biomedical Revolutionizes Vaccine Storage and Transportation
H2O2 Sterilizer: efficient solution
HB Innovates for Global Health and Immune
Vaccines are the foremost defense against infectious diseases, playing a pivotal role in safeguarding both individual and public health, as well as national security. Recognizing the importance of safe vaccination, Haier Biomedical addresses the industry's pain points head-on, offering holistic solutions tailored to ensure a safer and more efficient vaccination process, including intelligent vaccine deployment strategies adaptable to diverse scenarios, global cold chain solutions for vaccines, and innovative immunotherapy products. This empowers and strengthens the high-quality development of global immunization initiatives.
Biosafety Cabinets: Tips for Best Practices
The class of BSC can be further characterised by whether air is recirculated or ducted out of the building. The option that you choose will depend on the severity of risk to the environment and laboratory personnel from the contaminated air according to the BSL. It is important to remember that HEPA filters only extract particles, they do not remove vapours or gases, so these will not be filtered out of the air.
Global Spotlight on Haier Biomedical: Brand Excellence Captivates Worldwide
In an era marked by rapid advancements in the biomedical industry and the increasing globalization of enterprises, Haier Biomedical emerges as a beacon of innovation and excellence. As a foremost international leader in life sciences, the brand stands at the forefront of medical innovation and digital solutions, dedicated to safeguarding and enhancing life and health worldwide. With a relentless commitment to technological advancement, Haier Biomedical not only serves the needs of the life sciences and medical sectors but also proactively adapts to the evolving landscape. By embracing change, forging new pathways, and seizing emerging opportunities, the brand continually enhances its competitiveness and drives transformative progress both within and beyond its realm.